Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up Kaira Mara Cordeiro de Albuquerque; Caroline Brandão Joventino; Lia Correia Moreira; Hermano Alexandre Lima Rocha; Lívia Andrade Gurgel; Deivide de Sousa Oliveira; Carlos Ewerton Maia Rodrigues;

Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax Keli Lima; Hugo Passos Vicari; Jorge Antonio Elias Godoy Carlos; Jean Carlos Lipreri da Silva; Lorena Lobo de Figueiredo-Pontes; Eduardo Magalhães Rego; João Agostinho Machado-Neto;

A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia Brunno Gilberto Santos de Macedo; Manuela Albuquerque de Melo; Diego Antonio Pereira-Martins; João Agostinho Machado-Neto; Fabiola Traina;